Global Medical REIT Inc.
Global Medical REIT Inc. Fundamental Analysis
Global Medical REIT Inc. (GMRE) shows weak financial fundamentals with a PE ratio of 192.47, profit margin of 1.69%, and ROE of 0.49%. The company generates $0.1B in annual revenue with weak year-over-year growth of -1.79%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 9.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GMRE's fundamental strength across five key dimensions:
Efficiency Score
WeakGMRE struggles to generate sufficient returns from assets.
Valuation Score
ModerateGMRE shows balanced valuation metrics.
Growth Score
WeakGMRE faces weak or negative growth trends.
Financial Health Score
WeakGMRE carries high financial risk with limited liquidity.
Profitability Score
ModerateGMRE maintains healthy but balanced margins.
Key Financial Metrics
Is GMRE Expensive or Cheap?
P/E Ratio
GMRE trades at 192.47 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, GMRE's PEG of -2.86 indicates potential undervaluation.
Price to Book
The market values Global Medical REIT Inc. at 0.99 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -2.90 times EBITDA. This is generally considered low.
How Well Does GMRE Make Money?
Net Profit Margin
For every $100 in sales, Global Medical REIT Inc. keeps $1.69 as profit after all expenses.
Operating Margin
Core operations generate 24.86 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.49 in profit for every $100 of shareholder equity.
ROA
Global Medical REIT Inc. generates $0.20 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Global Medical REIT Inc. generates strong operating cash flow of $72.48M, reflecting robust business health.
Free Cash Flow
Global Medical REIT Inc. generates strong free cash flow of $18.63M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $1.39 in free cash annually.
FCF Yield
GMRE converts 3.89% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
192.47
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.86
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.99
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.25
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.50
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.53
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.005
vs 25 benchmark
ROA
Return on assets percentage
0.002
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How GMRE Stacks Against Its Sector Peers
| Metric | GMRE Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 192.47 | 24.23 | Worse (Expensive) |
| ROE | 0.49% | 659.00% | Weak |
| Net Margin | 1.69% | 4497.00% | Weak |
| Debt/Equity | 1.50 | -22.14 (disorted) | Distorted |
| Current Ratio | 0.53 | 13.87 | Weak Liquidity |
| ROA | 0.20% | -1390.00% (disorted) | Weak |
GMRE outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Global Medical REIT Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
0.51%
Industry Style: Income, Inflation Hedge, REIT
GrowingEPS CAGR
141.35%
Industry Style: Income, Inflation Hedge, REIT
High GrowthFCF CAGR
-1.24%
Industry Style: Income, Inflation Hedge, REIT
Declining